Excellent results were seen in this surgical series reported for NTOS. Younger patients with shorter duration of symptoms with less narcotic use led to even better FRRS results in the second 5 years of surgical intervention. An established vascular practice for referrals for NTOS resulted in an increased number of appropriate patients for surgical intervention, requiring fewer lidocaine and/or Botox injections preoperatively.

No abstract

Conclusions: Genetic identification of CTDs is rapidly expanding, allowing for categorization of previously undiagnosed patients. Endovascular options are viable and useful when there is acceptable vascular morphology and the procedure is planned properly, potentially in a hybrid modality.

No abstract